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Edited by Lev KisselevAbstract Pseudouridine synthases catalyse the isomerisation
of uridine to pseudouridine in structural RNA. The pseudou-
ridine synthase TruD, that modiﬁes U13 in tRNA, belongs to a
recently identiﬁed and large family of pseudouridine synthases
present in all kingdoms of life. We report here the crystal
structure of Escherichia coli TruD at 2.0 A resolution. The
structure reveals an overall V-shaped molecule with an RNA-
binding cleft formed between two domains: a catalytic domain
and an insertion domain. The catalytic domain has a fold
similar to that of the catalytic domains of previously charac-
terised pseudouridine synthases, whereas the insertion domain
displays a novel fold.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Nucleotides of RNA undergo chemical modiﬁcation in all
organisms and the most abundant modiﬁcation is the con-
version of speciﬁc uridine (U) residues to pseudouridine (5-
ribosyluracil; w). Pseudouridine is unique in possessing a C–C
bond rather than the N–C glycosidic bond usually present in
nucleotides. The post-transcriptional isomerisation of U to w is
catalysed by pseudouridine synthases in a variety of structural
RNAs, including tRNA, rRNA and sn(o)RNA. Site speciﬁcity
is obtained through the presence of a set of pseudouridine
synthases, each speciﬁc for one or, at the most, three modiﬁ-
cation sites.
Four distinct families of pseudouridine synthases have been
deﬁned based on sequence analysis: TruA, TruB, RsuA and
RluA [1,2]. The only common conserved sequence feature
between these families is a short motif [2] containing an as-
partate residue essential for the catalytic activity [3,4]. Struc-
tural studies of members in the TruA, TruB, RsuA and RluA
families have revealed that even though the enzymes have low
sequence similarity, their catalytic domains have similar
overall structure and also identical location of the conserved* Corresponding author. Fax: +46-8-5537-8358.
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doi:10.1016/j.febslet.2004.03.085aspartate residue in the active site. This implies a common
ancestry of the pseudouridine-synthase families [5–11].
The mechanism of the pseudouridine-synthase catalysed
isomerisation is debated but evidence is accumulating that the
reaction proceeds through a covalent intermediate formed
between an aspartate residue and C6 of U, allowing a 180
rotation of the pyrimidine, and the subsequent re-ligation re-
sulting in a C–C glycosidic bond [3]. Some, but not all, pseu-
douridine synthases are inhibited by 5-ﬂuorouridine, rather
than U, at the site of modiﬁcation. The ﬂuorine interferes with
the re-ligation step, causing the enzyme to be trapped with a
covalent adduct at the catalytic Asp [3,12,13]. Co-crystal
structures of TruB and stem-loop RNA 5-ﬂuorouridine-based
inhibitors have been determined [6,8], but unfortunately none
of these structures display a covalent intermediate. Recent in-
vestigations show that TruB is not able to form a covalent
adduct with 5-ﬂuorouridine in solution [13], thus, additional
co-crystal structures with pseudouridine synthases that have
been successfully inhibited by 5-ﬂuorouridine are needed to
shed light on the mechanism.
Recently, a new pseudouridine-synthase family, with no
sequence homology to known pseudouridine synthases, was
identiﬁed. A yeast representative, pus7p, was found to modify
position U35 in Saccharomyces cerevisiae U2 snRNA, U13 in
yeast tRNA and U35 in pre-tRNATyr [14,15]. The presence of
w35 in U2 snRNA is important for high splicing eﬃciency in
S. cerevisiae in that it re-sculptures the spliceosomal branch
site to enable the ﬁrst step of splicing [16]. Independently of the
yeast work, the search for the pseudouridine synthase re-
sponsible for the modiﬁcation of U13 in tRNAGlu in E. coli
revealed a pus7p orthologue [17]. The gene, ygbO, encoding a
polypeptide of 39 kDa, was renamed TruD, representing the
fourth tRNA-modifying pseudouridine synthase to be char-
acterised. Following the convention to name each pseudouri-
dine-synthase family after the ﬁrst E. coli enzyme to be cloned,
this new family of pseudouridine synthases is referred to as the
TruD family. In a database search, 58 representatives of the
TruD family were detected of which 24 are from Eubacteria,
19 from Archea and 16 from Eukarya [17]. Previously known
RNA-binding motifs were not represented among the six
motifs identiﬁed, indicating that this class of proteins should
contain novel RNA-binding sequences [17]. Mutational studies
of the only completely conserved aspartate (Asp80 in E. coli
and Asp256 in S. cerevisiae) showed that it is essential for in
vitro activity [15,17]. Here, we describe the crystal structure of
E. coli TruD that represents the ﬁrst 3D structure from thisblished by Elsevier B.V. All rights reserved.
Table 1
Data collection, phasing and reﬁnement statistics
Se-Met Peak Se-Met Highres
Cell constants a, b, ca (A) 63.56, 108.5, 112.2 63.18, 108.1, 112.5
Wavelength (A) 0.97970 0.93219
Resolution (A) 35–2.55 (2.64–2.55) 35–2.0 (2.1–2.0)
Unique/observed reﬂections 25 511/91 839 52 753/467 504
Completeness (%) 97.4 (80.0) 99.8 (100.0)
hI=rðIÞi 18.3 (3.16) 15.9 (5.35)
Rsym 9.6 (31.3) 7.2 (36.0)
Anomalous signal-to-noise ratiob 1.76 (1.14) –
CC (All/Weak)c 33/17.6 –
Rwork/Rfree
d (%) – 19.5/24.3
RMSD bond lengths (A)/angles () – 0.020/2.0
Ramachandran plot outlierse (%) – 2.0
a Space group P212121.
b hjF þ  Fj=rðF þ  F Þi as calculated by XPREP (Bruker AXS).
c Correlation coeﬃcient as a measure for the agreement between E2o and E
2
c ; expressed as a percentage for the best solution in SHELXD [21].
d 3.1% of reﬂections excluded from reﬁnement.
e Percentage of residues that fall outside core regions of the Ramachandran plot [34].
Fig. 1. (A) Unbiased electron density from RESOLVE [23] contoured at 1r around parts of motif 5 in the insertion domain. (B) Ribbon diagram of
E. coli TruD. The catalytic domain (residues 1–155 and 304–341) is in blue and the insertion domain (residues 156–303) is in beige. The proposed
catalytic aspartate is shown in stick representation. The loop between residues 180 and 187 is not present in the crystallographic model and is
represented by a dotted curve in the picture. Molecule A was used in this ﬁgure. (C) A molecular surface representation of TruD coloured by the local
electrostatic potential (blue, +8 kT; red )5 kT). The surface of the catalytic Asp80 is shown in orange. (For interpretation of the references to colour
in this ﬁgure legend, the reader is referred to the web version of this article.)
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uridine synthases.2. Materials and methods
2.1. Structure determination
TruD was expressed, puriﬁed and crystallised as described elsewhere
[18] with the modiﬁcation that the methionine pathway inhibition
method [19] was used to obtain selenomethionine-substituted protein. A
single-wavelength anomalous dispersion data set was collected at
beamline PSF-BL1 (BESSY, Berlin, Germany) (Table 1). Diﬀraction
data were processed and scaled with HKL2000 using an empirical ab-
sorption correction to maximise the anomalous signal [20]. After data
preparation with XPREP (Bruker AXS), seven out of eight possible
selenium sites were identiﬁed with SHELXD [21]. The identiﬁed sele-
nium positions were used to calculate phases with the program SOLVE
[22]. Density modiﬁcation using RESOLVE [23] produced an easily in-
terpreted electron density map (Fig. 1A).
A higher resolution data set (Table 1) was collected for automatic
model building in ARP/wARP [24] and was processed with the XDS
package [25]. The resulting crystallographic model was reﬁned using
REFMAC5 [26] with alternating rebuilding with O [27]. Only one re-
gion (residues 180–187) was poorly resolved and did not allow model
building. A solvent model was built automatically in the ARP/wARP
package. Coordinates and structure factors have been deposited in the
PDB (ID code: 1SZW).
Rigid-body docking calculations of the complex between tRNA
from 1J2B [28] and TruD were performed with the program HEX [29]Fig. 2. Structure-based multiple sequence alignment of members in the TruD
Swiss-Prot organism code (ECOLI, E. coli; HELPY, Helicobacter pylori; H
Homo sapiens) followed by its gi number. Secondary-structure elements a
alignment. Sequence conservation is shown according to Zappo colour codin
hydrophilic, blue; conformationally special, magenta). Conserved sequence
sequences are marked by the number of excluded residues. The catalytic as
denoted as in Fig. 1B. (For interpretation of the references to colour in thisby a global search using a ligand, receptor and twist range of 180,
180 and 360, respectively.3. Results and discussion
3.1. Overall structure
TruD is a V-shaped molecule (Fig. 1B) with two structurally
distinct domains: a catalytic domain (20 26 53 A3; resi-
dues 1–155 and 304–341) and an insertion domain
(22 26 45 A3; residues 156–303). A hinge provides nu-
merous inter-domain interactions at the bottom of the V and
an extended, quite narrow cleft between the two domains. The
rendering of an electrostatic surface on TruD exposes a rift
with strong positive charge between the two domains and
positive surfaces at the top of the V (Fig. 1C). These surfaces
are the most probable sites of tRNA interaction. A structural
alignment of TruD-related pseudouridine-synthase sequences
(Fig. 2) reveals that the eukaryotic members have two inser-
tions: one N-terminal, and one after strand B2. These inser-
tions may encode domains necessary for recognition of
substrates exclusive to eukaryotes. The six motifs identiﬁed
previously [17] are all found along the cleft between the two
domains in the structure. The two molecules constituting the
crystal asymmetric unit have slightly diﬀerent inter-domainfamily of pseudouridine synthases. Each homologue is denoted with its
ALN1, Halobacterium sp. NRC-1; YEAST, S. cerevisiae; HUMAN,
re shown above and consensus residues (at 80% identity) below the
g (i.e., aliphatic, pink; aromatic, orange; positive, red; negative, green;
motifs are denoted below the alignment. Insertions in the eukaryotic
partate is denoted with an asterisk. Secondary-structure elements are
ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 3. (A) Superposition of TruD and TruA. TruD has the same
colouring scheme as in Fig. 1(B). TruA is coloured in pink with its
catalytic aspartate (D60) in stick representation (green). Secondary-
structure elements are denoted as in Fig. 1B. Molecule A of TruD was
used in this ﬁgure. (B) Superposition of universally conserved struc-
tural features in the active-site region, also including the 5-ﬂuoro-6-
hydroxy-pseudouracil from TruB (1K8W). Colour scheme: TruD
ribbon in blue, side chains in gold; RsuA (1KSK) in grey; TruA
(1DJO) in green; TruB (1K8W) in magenta (phosphate in beige); RluD
(1PRZ) in pink. Secondary-structure elements are denoted as in Fig.
1B. Molecule A of TruD was used in this ﬁgure. (For interpretation of
the references to colour in this ﬁgure legend, the reader is referred to
the web version of this article.)
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This is manifested in a more closed overall V-shape in one of
the molecules, highlighting signiﬁcant plasticity of the TruD
molecule. Furthermore, during the review process of this
manuscript, a crystal structure of E. coli TruD was reported
elsewhere [30], independently of our work. Although similar in
shape, the other TruD model appears to have a more closed
overall V-shape compared with the structure reported here.
This stresses further the plasticity of the TruD molecule.
3.2. The catalytic domain of TruD reveals structural
conservation in the absence of sequence identity
Although there is no signiﬁcant sequence homology, the
catalytic domain is dominated by a large curved b-sheet fea-
turing the tandem ferredoxin-like fold found in the catalytic
domains of the previously characterised pseudouridine syn-
thases. A DALI [31] search with the catalytic domain as a
search probe returns TruA as the structurally most similar
protein (Fig. 3A), followed by the catalytic subunits of TruB
and RsuA. An optimised superposition of the available pseu-
douridine-synthase structures to TruD (Table 2) with the
program O [27] reveals a sequence identity of the structural
superposition approaching the limit of random alignment [32].
However, the structural and functional similarity supports a
divergent evolution from a common ancestry.
The proposed catalytic residue Asp80 [17] is the only
structurally conserved residue in the active site. However, two
structural features are retained, highlighting their importance
for recognition and catalysis. The residue Phe131 is conserved
in the TruD family, while it is a conserved tyrosine in the other
pseudouridine-synthase families. In the modelled TruB-TSL
precursor complex [6], this residue (Tyr76 in TruB) makes a
stacking interaction with the base to be modiﬁed (U55),
thereby orienting it for catalysis. Similarly, a conserved leucine
residue (Leu200, TruB numbering) is involved in stacking with
U55 in TruB and superimposes well with a phenylalanine
(Phe27) conserved in the TruD family (Fig. 3B). A feature
exclusive to TruB and TruD is Tyr179 (TruB numbering) that
is proposed to stabilise a reaction intermediate [6]. The cor-
responding residue (Phe329) in the TruD family is either a Phe
or a Tyr (Fig. 2). Similar to other pseudouridine synthases, a
catalytic pocket that can accept the ﬂipped-out U to be mod-
iﬁed is formed in TruD. Although substrate recognition is
idiosyncratic in pseudouridine synthases, the catalytic pocket
and the overall structural conservation of the active site indi-
cates that pseudouridine synthases have a common catalytic
reaction mechanism. The loop that contains motif 2 (Fig. 2)
adopts diﬀerent conformations in the A and B molecule of the
asymmetric unit. Interestingly, the displacement is particularly
pronounced for Asp80 (4.6 A on CaÞ.
3.3. The insertion domain has a new fold
The insertion domain features a mixed a=b structure domi-
nated by an extended 24-residue a-helix. A search with DALI
[31] revealed no signiﬁcant structural similarity to any entry in
the PDB. Thus, the structure of this domain constitutes a new
protein fold, and considering the strong positive charge present
on the side facing the catalytic domain, the inserted domain is
most likely involved in RNA binding (Fig. 1C). Sequence
conservation in this domain is localised to the side of the long
a-helix that faces the cleft between the domains (motif 5). A
basic local alignment search tool [33] search for short, almostperfect matches using motif 5 as a search template revealed
high local sequence similarity with a part of the Arabidopsis
thaliana RecQ DNA-helicase (gi:12320889), implying that the
insertion domain may have a relative involved in DNA inter-
action.
The domain is inserted in one of the ferredoxin-like units in
the catalytic domain, suggesting that the insertion occurred
after the gene duplication event presumed to have generated
the tandem ferredoxin-like fold of the catalytic domains of
pseudouridine synthases [9]. The structure of TruD is the ﬁrst
example of a structurally characterised pseudouridine synthase
that has an external domain as an insertion in the primary
structure of the catalytic domain.
3.4. Interaction with tRNA
The nucleotide modiﬁed by TruD, U13, resides in the D-
loop that is part of the structural core of tRNA. This is the
Table 2
Optimised structural superimpositiona of pseudouridine synthases and the sequence identity based on the structural alignment
TruA (1DJ0) TruB (1K8W) RsuA (1KSK) RluD (1PRZ)b TruDc
TruA – 15% 10% 10% 8%
TruB 1.7 A; 107 Ca – 23% 19% 8%
RsuA 2.0 A; 106 Ca 1.5 A; 110 Ca – 21% 11%
RluD 2.3 A; 91 Ca 1.9 A; 115 Ca 1.7 A; 105 Ca – 12%
TruD2 2.1 A; 118 Ca 2.2 A; 122 Ca 2.2 A; 92 Ca 2.1 A; 91 Ca –
a The structures were searched in the program O [27] for the longest possible matching structural fragments of at least three residues for which each
atom pair could be aligned within a distance of 3.8 A.
b 1QYU is very similar to 1PRZ and is therefore not used in this comparison.
cMolecule A was used in the structural superimposition.
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Any post-transcriptional modiﬁcation of residues in the D-
loop would need a partial unfolding of the L-shaped structure
of tRNA. This hypothesis was corroborated by the recent
co-crystal structure of an archeosine tRNA–guanine trans-
glycosylase [28], which exchanges G15 in archeal D-loops to a
7-cyano-7 deazaguanine by transglycosylation. In this struc-
ture, the canonical core and the D-loop of the bound tRNA
are unfolded. The D-stem protrudes to form a lip giving the
tRNA a k-form, thus enabling the enzyme the access necessary
to exchange G15. Following initial, unsatisfactory, attempts to
dock the relatively wide classical L-form of tRNA into the
narrow cleft between the two domains in TruD, the k-form of
tRNA from the archeosine tRNA–guanine transglycosylase
structure (PDB entry 1J2B; [28]) was docked to TruD. The
dominant solutions clustered in a docking mode where the
single-stranded D-loop penetrates into the rift between the two
domains (Fig. 4). The interaction surface of the complex is
extensive (3900 A2), and has a high degree of charge and shape
complementarity. Interestingly, the only disordered part of the
TruD structure described here (residues 180–187 in the inser-
tion domain) would be able to interact with the exposed coreFig. 4. A rigid-docking model of TruD with the k-form of tRNA from
the structure of archeosine tRNA–guanine transglycosylase (PDB
entry 1J2B; [28]). The surface of the catalytic Asp80 is shown in
orange, whereas the site to be modiﬁed (U13) is coloured green on the
k-tRNA phosphate backbone ribbon. The molecular surface is col-
oured by its local electrostatic potential (blue, +8 kT; red )5 kT).
(For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)of the tRNA molecule so as to stabilise the unfolded D-stem, a
role similar to that of the b18–b19 hairpin in the archeosine
tRNA–guanine transglycosylase [28]. In this model, the func-
tion of the insertion domain would be to recognise and sta-
bilise the k-form of tRNA. Given the extensive ﬂexibility of the
hinge region, as shown by the discrepancy between the two
molecules constituting the crystal asymmetric unit, we cannot
exclude the possibility that the cleft between the domains can
widen enough to allow entry of the L-form of tRNA. How-
ever, in that case, the problem with accessing U13 would still
remain.
3.5. Conclusions and future prospects
The crystal structure of TruD is the ﬁrst from a new and
widely distributed family of pseudouridine synthases with
representatives from all kingdoms of life. The structure reveals
two domains: one that has the same overall fold and location
of the active site as the catalytic domains observed in other
pseudouridine synthases, and a smaller domain that displays a
novel fold inserted into the primary structure of the catalytic
domain. It provides a structural basis for further biochemical,
biophysical and genetic studies on members of this family.
Future challenges include investigation of co-crystal structures
with full-length tRNA to understand how recognition and
catalysis is achieved at a molecular level.
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